Insider Trading March 30, 2026

IperionX Director Tripeny R Tony Buys $99,463 Worth of Shares

Director increases direct stake as company begins commercial titanium production and draws fresh analyst coverage

By Caleb Monroe IPX
IperionX Director Tripeny R Tony Buys $99,463 Worth of Shares
IPX

Director Tripeny R Tony acquired 4,187 American Depositary Shares of IPERIONX Ltd on March 27, 2026, for $23.7554 per share, a transaction valued at $99,463. The purchase leaves the director with direct holdings across ADS, ordinary shares, and RSUs while the company moves into commercial production and receives new analyst coverage.

Key Points

  • Director Tripeny R Tony bought 4,187 ADS of IPERIONX Ltd on March 27, 2026, at $23.7554 per share, totaling $99,463.
  • Post-transaction, Tony holds 4,187 ADS, 38,777 Ordinary Shares, and 51,010 RSUs; RSUs vest in December 2026 and December 2027.
  • IPERIONX has begun commercial production in Virginia with an initial target of ~200 tonnes of titanium per annum this year and plans to scale to ~1,400 tonnes next year; BTIG and William Blair have initiated coverage.

Summary

Tripeny R Tony, a director of IPERIONX Ltd (NASDAQ:IPX), purchased 4,187 American Depositary Shares on March 27, 2026, at $23.7554 per ADS, for a total transaction value of $99,463. The acquisition increased Tony's direct ADS position while the company advances production at its Virginia facility and attracts coverage from multiple analysts.


Transaction details

The director's purchase was executed at $23.7554 per American Depositary Share (ADS) on March 27, 2026, for an aggregate cost of $99,463. At the time of the report, IPERIONX's stock was trading at $23.15 and has declined 53% over the past six months from a 52-week high of $61.45. An InvestingPro assessment noted the relative strength index, or RSI, indicates the stock may be in oversold territory, which the analysis observed could have been a factor in the timing of the director's purchase.


Post-transaction holdings

Following the March 27 purchase, Tripeny R Tony directly holds 4,187 ADS, together with 38,777 Ordinary Shares and 51,010 Restricted Stock Units (RSUs) of IPERIONX Ltd. The company's RSU schedule includes 36,848 RSUs that vest in December 2026 and 14,162 RSUs that vest in December 2027.


Market context and valuation

IPERIONX currently has a market capitalization of $785.4 million. InvestingPro data referred to in the report indicates the stock is slightly overvalued relative to its Fair Value. The InvestingPro platform also provides additional analytical material, including 10 supplementary ProTips and broader financial metrics for investors who seek further detail.


Analyst activity and production updates

Recent analyst attention has accompanied the company as BTIG initiated coverage with a Buy rating and established a $40.00 price target. William Blair also began covering IPERIONX, assigning an Outperform rating. Operationally, IPERIONX has started commercial production at its Virginia facility, targeting an initial output of roughly 200 tonnes of titanium per annum this year with plans to ramp production to about 1,400 tonnes per annum next year. The analysts cited the company’s potential to scale titanium powder production and related component manufacturing capabilities as part of their thesis.


What this means

The director-level purchase adds to Tripeny R Tony’s direct and indirect ownership stakes while the company transitions into commercial manufacturing and draws fresh analyst coverage. Investors interested in more granular financial metrics and extra InvestingPro content can consult the platform for the additional ProTips referenced in the report.

Risks

  • Share price has fallen 53% over the past six months from a 52-week high of $61.45, indicating recent volatility in the stock - this impacts capital markets and investor sentiment.
  • InvestingPro data notes the stock is slightly overvalued relative to Fair Value, introducing valuation risk for equity investors in materials and industrials sectors.
  • RSU vesting is scheduled across two future dates (December 2026 and December 2027), which may affect insider-derived share supply and personnel retention considerations in the industrials and manufacturing sectors.

More from Insider Trading

GlobalFoundries’ CLO Disposes of $22,995 in Stock as Company Faces Legal and Capital Moves Mar 30, 2026 Lemonade Director Increases Stake with $485k in Stock Purchases Mar 30, 2026 Neuronetics Insider Adds $675,000 in Shares as Company Reports Mixed Q4 Results Mar 30, 2026 Horace Mann CMO Makes Modest Stock Purchase as Company Posts Strong Q4 Results Mar 30, 2026 IperionX President Purchases $262,552 in ADS as Coverage Begins and Production Ramps Mar 30, 2026